These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 12088265)

  • 21. Evaluation and therapy of the patient with fecal occult blood loss: a decision analysis.
    Lashner BA; Silverstein MD
    Am J Gastroenterol; 1990 Sep; 85(9):1088-95. PubMed ID: 2117850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of an incomplete preoperative colonoscopy in patients with colorectal cancer.
    Scintu F; D'Alia G; Cabras M; Zorcolo L; Melis M; Marongiu L; Casula G
    Chir Ital; 2000; 52(2):103-7. PubMed ID: 10832535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of diagnostic methods in adenoma follow-up.
    Williams CB; Macrae FA; Bartram CI
    Endoscopy; 1982 May; 14(3):74-8. PubMed ID: 7075563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.
    Gingold-Belfer R; Leibovitzh H; Boltin D; Issa N; Tsadok Perets T; Dickman R; Niv Y
    United European Gastroenterol J; 2019 Apr; 7(3):424-448. PubMed ID: 31019712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
    N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer screening.
    Borum ML
    Prim Care; 2001 Sep; 28(3):661-74, viii. PubMed ID: 11483450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.
    Robinson MH; Hardcastle JD; Moss SM; Amar SS; Chamberlain JO; Armitage NC; Scholefield JH; Mangham CM
    Gut; 1999 Oct; 45(4):588-92. PubMed ID: 10486370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
    Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of rehydration on guaiac-based faecal occult blood testing in colorectal cancer screening.
    Castiglione G; Biagini M; Barchielli A; Grazzini G; Mazzotta A; Salvadori P; Scillone L; Ciatto S
    Br J Cancer; 1993 May; 67(5):1142-4. PubMed ID: 8494714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of combined flexible sigmoidoscopy and double contrast barium enema in patients with rectal bleeding.
    Hixson LJ; Sampliner RE; Chernin M; Amberg J; Kogan F
    Eur J Radiol; 1989 Nov; 9(4):254-7. PubMed ID: 2591391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The correlation of symptoms, occult blood tests, and neoplasms in patients referred for double-contrast barium enema.
    Jensen J; Kewenter J; Swedenborg J
    Scand J Gastroenterol; 1993 Oct; 28(10):911-4. PubMed ID: 8266021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent advances in diagnosis and treatment of colorectal cancer].
    Tada M
    Rinsho Byori; 1990 Apr; 38(4):403-6. PubMed ID: 2195194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy.
    Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD
    Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of colonoscopy in screening persons with family history of colorectal cancer.
    Wu CS; Tung SY; Chen PC; Kuo YC
    J Gastroenterol Hepatol; 1995; 10(3):319-23. PubMed ID: 7548810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
    Hundt S; Haug U; Brenner H
    Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test.
    Kewenter J; Brevinge H; Engarås B; Haglind E
    Endoscopy; 1995 Feb; 27(2):159-63. PubMed ID: 7601048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT colonography: role in FOBT-based screening programs for colorectal cancer.
    Sali L; Grazzini G; Mascalchi M
    Clin J Gastroenterol; 2017 Aug; 10(4):312-319. PubMed ID: 28447326
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.